Heart valve hope: could a common supplement slow disease?
NCT ID NCT06466278
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether icosapent ethyl, a purified fish-oil medication, can slow the buildup of calcium in the aortic valve. About 110 adults with mild-to-moderate aortic valve stenosis will take the drug or a placebo. The main goal is to see if the drug reduces the increase in valve calcium over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Academic Medical Center
Amsterdam, 1105AZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single stitch beat a double closure for TAVI patients?
- Can a fitness app boost recovery after heart valve replacement?
- A new heart valve without Open-Heart surgery: can it help High-Risk patients?
- Can a single antiplatelet drug beat aspirin after heart valve replacement?
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Which heart valve works best for small aortic openings? a Head-to-Head trial